vrapc.com
VRA Clinical Trials
http://www.vrapc.com/pages/clinical_trials/inside.html
VRA - Grand Rapids. 2505 East Paris Ave. SE. Suite 100 Grand Rapids, MI 49546 (616) 285-1200. 1080 North 10th Street Suite 100 Kalamazoo, MI 49009 (269) 353-9700. 3102 Glade Street Muskegon, MI 49444 (231) 830-1200. Investigator Initiated Protocol SM09-0626-01 Lipid and Cytokine Analysis of Vitreous Samples from Clinically Indicated Vitrectomies. DRCR Protocol V treatment for DME in eyes with very good VA. Describing the DRCR Protocol V. Roche Study of Lampalizumab. Ohr-1601 study of topical Squalamine.
geographicatrophytrials.com
Study criteria for Chroma and Spectri clinical trials for GA
http://www.geographicatrophytrials.com/hcp/clinical-trial-study-criteria
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Patients must meet the following criteria for study entry:. Ages Eligible for Study. 50 years and older. Genders Eligible for Study. Well-demarcated area(s) of GA secondary to AMD with no evidence of prior or active choroidal neovascularization (CNV). Patients who meet any of the following criteria will be excluded from study entry:. Ocular Exclusion Criteria: Study Eye. The link you selected will take y...
geographicatrophytrials.com
Geographic Atrophy Patient Support
http://www.geographicatrophytrials.com/hcp/patient-support
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Resources and support for patients with Geographic Atrophy. A diagnosis of Geographic Atrophy can be stressful and overwhelming for many patients. You can help your patients gain a better understanding of their disease, learn about the clinical trials that are currently recruiting eligible GA patients, and learn new ways to make living with GA easier.
geographicatrophytrials.com
Patient FAQs
http://www.geographicatrophytrials.com/hcp/patient-faqs
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. COMMONLY ASKED QUESTIONS BY PATIENTS. Commonly Asked Questions by Patients. No doubt, your patients will have questions regarding the Chroma and Spectri clinical trials. Here is a list of some of the more common questions and their answers. What is the purpose of the studies? Why do researchers think the approach may be effective? Why should I participate in the study? By participating in the GA research...
geographicatrophytrials.com
Lampalizumab Clinical Trials
http://www.geographicatrophytrials.com/hcp/explore-lampalizumab-clinical-trials
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Explore lampalizumab clinical trials. Your patients may be eligible to participate in clinical trials sponsored by Genentech/Roche. Proxima A and B. Proxima A and B are global, prospective, multicenter, epidemiologic studies of patients with GA secondary to AMD. Proxima A and B will enroll approximately 560 patients (360 in Proxima A and 200 in Proxima B) in approximately 140 sites globally. NCT02399072)...
geographicatrophytrials.com
Patient resources to help make living with GA easier
http://www.geographicatrophytrials.com/hcp/ga-patient-resources
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Helpful resources for your patients with GA. While your patients are participating in the study, several support programs and resources will be available to help make living with Geographic Atrophy easier. Support groups are an excellent way for your patients to share stories and insights with others who have GA. Find a support group. Online advocacy groups, such as AMD.org. The link you selected will ta...
geographicatrophytrials.com
Trial support materials for patients participating in Chroma or Spectri clinical trials
http://www.geographicatrophytrials.com/hcp/patient-trial-support-materials
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. If your patients are already participating in the Chroma or Spectri clinical trials and are interested in additional study materials, there are several resources you can use to help them gain a better understanding about their disease and what to expect during the trials. A patient study guide. To order more copies, please contact your CRA.
geographicatrophytrials.com
What is Lampalizumab?
http://www.geographicatrophytrials.com/hcp/lampalizumab-clinical-trials
Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. Go to Patient and Caregiver Site. The pathogenesis of AMD is complex and not well understood; however, genetics and environmental factors (such as smoking), as well as the alternative complement pathway (ACP), have all been implicated in AMD pathophysiology. By inhibiting ACP activity, lampalizumab may offer the potential to reduce both the speed of GA progression and vision loss. De Jong PT. Age-related macular degeneration. N Engl J Med.